116 related articles for article (PubMed ID: 17631730)
1. Serum lipids and anti-oxidized LDL antibodies in primary antiphospholipid syndrome.
Bećarević M; Andrejević S; Miljić P; Bonaci-Nikolić B; Majkić-Singh N
Clin Exp Rheumatol; 2007; 25(3):361-6. PubMed ID: 17631730
[TBL] [Abstract][Full Text] [Related]
2. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome.
Becarevic M; Singh S; Majkic-Singh N
Clin Lab; 2008; 54(3-4):97-101. PubMed ID: 18630740
[TBL] [Abstract][Full Text] [Related]
3. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
Bećarevic M; Andrejević S; Bonaci-Nikolić B; Obradović I; Miljić P; Majkić-Singh N
Clin Lab; 2005; 51(5-6):279-83. PubMed ID: 15991801
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
Ames PR; Matsuura E; Batuca JR; Ciampa A; Lopez LL; Ferrara F; Iannaccone L; Alves JD
Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome.
Cuadrado MJ; Tinahones F; Camps MT; de Ramon E; Gómez-Zumaquero JM; Mujic F; Khamashta MA; Hughes GR
QJM; 1998 Sep; 91(9):619-26. PubMed ID: 10024916
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
Pengo V; Bison E; Ruffatti A; Iliceto S
Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
[TBL] [Abstract][Full Text] [Related]
7. [Oxidatively modified lipoproteins and their antibodies in patients with antiphospholipid syndromeand systemic lupus erythematosus].
Roch B; Kopprasch S; Pietzsch J; Schröder HE
Z Rheumatol; 2004 Aug; 63(4):331-7. PubMed ID: 15338257
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
Zhao D; Ogawa H; Wang X; Cameron GS; Baty DE; Dlott JS; Triplett DA
Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
[TBL] [Abstract][Full Text] [Related]
9. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary data.
Bećarević M; Ignjatović S
Clin Rheumatol; 2016 Oct; 35(10):2477-83. PubMed ID: 27370963
[TBL] [Abstract][Full Text] [Related]
11. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
[TBL] [Abstract][Full Text] [Related]
12. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
de Souza AW; Silva NP; de Carvalho JF; D'Almeida V; Noguti MA; Sato EI
Lupus; 2007; 16(10):782-7. PubMed ID: 17895300
[TBL] [Abstract][Full Text] [Related]
13. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
14. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
[TBL] [Abstract][Full Text] [Related]
16. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte subpopulations and intima media thickness in primary antiphospholipd syndrome.
Ames PR; Tommasino C; Fossati G; Matsuura E; Margarita A; Saulino A; Lopez L; Scenna G; Brancaccio V
Lupus; 2005; 14(10):809-13. PubMed ID: 16302675
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against beta2-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome.
Ames PR; Delgado Alves J; Lopez LR; Gentile F; Margarita A; Pizzella L; Batuca J; Scenna G; Brancaccio V; Matsuura E
Clin Dev Immunol; 2006 Mar; 13(1):1-9. PubMed ID: 16603439
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis, antiphospholipid syndrome, and antiphospholipid antibodies.
Nicolo D; Varadhachary AS; Monestier M
Front Biosci; 2007 Jan; 12():2171-82. PubMed ID: 17127454
[TBL] [Abstract][Full Text] [Related]
20. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
